盈康生命(300143.SZ):總經理變更爲馬安捷
格隆匯6月18日丨盈康生命(300143.SZ)公佈,公司董事會於2025年6月18日收到了公司董事、總經理兼法定代表人彭文先生、副總經理馬安捷先生的書面辭職報告。彭文先生因個人原因申請辭去公司董事、總經理兼法定代表人職務,同時一併辭去薪酬與考覈委員會委員及提名委員會委員一職,彭文先生原定的任職日期至2026年9月27日,辭職後不再擔任公司任何職務。
經公司董事長譚麗霞女士推薦,董事會提名委員會審覈通過,公司董事會同意聘任馬安捷先生爲公司總經理,任期自本次董事會審議通過之日起至第六屆董事會屆滿之日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.